Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
zolpidem tartrate
|
| gptkbp:approvalYear |
2008
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N05CF02
|
| gptkbp:controlledSubstanceSchedule |
Schedule IV (US)
|
| gptkbp:form |
oral spray
metered spray |
| gptkbp:halfLife |
2.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zolpimist
|
| gptkbp:indication |
insomnia
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Aytu BioPharma
NovaDel Pharma |
| gptkbp:mechanismOfAction |
GABA-A receptor agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
dizziness headache drowsiness |
| gptkbp:website |
https://zolpimist.com/
|
| gptkbp:bfsParent |
gptkb:zolpidem
|
| gptkbp:bfsLayer |
6
|